These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9421360)

  • 1. Microsatellite analysis and telomerase activity in archived tissue and urine samples of bladder cancer patients.
    Linn JF; Lango M; Halachmi S; Schoenberg MP; Sidransky D
    Int J Cancer; 1997 Dec; 74(6):625-9. PubMed ID: 9421360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microsatellite alterations in human bladder cancer: detection of tumor cells in urine sediment and tumor tissue.
    Berger AP; Parson W; Stenzl A; Steiner H; Bartsch G; Klocker H
    Eur Urol; 2002 May; 41(5):532-9. PubMed ID: 12074795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic instability analysis of urine sediment versus tumor tissue in transitional cell carcinoma of the urinary bladder.
    Turyn J; Matuszewski M; Schlichtholz B
    Oncol Rep; 2006 Jan; 15(1):259-65. PubMed ID: 16328066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microsatellite alterations in urinary sediments from patients with cystitis and bladder cancer.
    Christensen M; Wolf H; Orntoft TF
    Int J Cancer; 2000 Mar; 85(5):614-7. PubMed ID: 10699938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Microsatellite instability in urine sediments from patients with transitional cell carcinoma of bladder and its clinical value].
    Lü Y; Tang D; Yu L; Ding Y; Liu L; Guo Y
    Zhonghua Wai Ke Za Zhi; 2000 Apr; 38(4):294-6. PubMed ID: 12828175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum DNA and urine DNA alterations of urinary transitional cell bladder carcinoma detected by fluorescent microsatellite analysis.
    von Knobloch R; Hegele A; Brandt H; Olbert P; Heidenreich A; Hofmann R
    Int J Cancer; 2001 Oct; 94(1):67-72. PubMed ID: 11668480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitive detection of transitional cell carcinoma of the bladder by microsatellite analysis of cells exfoliated in urine.
    Seripa D; Parrella P; Gallucci M; Gravina C; Papa S; Fortunato P; Alcini A; Flammia G; Lazzari M; Fazio VM
    Int J Cancer; 2001 Nov; 95(6):364-9. PubMed ID: 11668518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum, plasma and urine samples.
    Dahse R; Utting M; Werner W; Schimmel B; Claussen U; Junker K
    Int J Oncol; 2002 Jan; 20(1):107-15. PubMed ID: 11743649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Microsatellite analysis in exfoliated cells from urinary sediment. Its utility for the detection of bladder cancer. Comparison with urinary cytology].
    Molina Burgos R; Millán Salvador JM; Oltra Soler JS; Jiménez Cruz JF
    Actas Urol Esp; 2003 Sep; 27(8):618-28. PubMed ID: 14587237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective evaluation of genetic abnormalities and telomerase expression in exfoliated urinary cells for bladder cancer detection.
    Neves M; Ciofu C; Larousserie F; Fleury J; Sibony M; Flahault A; Soubrier F; Gattegno B
    J Urol; 2002 Mar; 167(3):1276-81. PubMed ID: 11832713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of loss of heterozygosity in the p53 tumor-suppressor gene with PCR in the urine of patients with bladder cancer.
    Friedrich MG; Erbersdobler A; Schwaibold H; Conrad S; Huland E; Huland H
    J Urol; 2000 Mar; 163(3):1039-42. PubMed ID: 10688045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transitional cell bladder tumor: predicting recurrence and progression by analysis of microsatellite loss of heterozygosity in urine sediment and tumor tissue.
    Fornari D; Steven K; Hansen AB; Jepsen JV; Poulsen AL; Vibits H; Horn T
    Cancer Genet Cytogenet; 2006 May; 167(1):15-9. PubMed ID: 16682280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Loss of heterozygosity of tumor suppressor genes at chromosome 3p in transitional cell carcinoma of urinary bladder].
    Xiao Z; Zhang J; Zheng S; Li C; He Z; Cheng S; Gao Y
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1375-7. PubMed ID: 12509916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microsatellite analysis of urine sediment versus urine cytology for diagnosing transitional cell tumors of the urinary bladder.
    Fornari D; Steven K; Hansen AB; Vibits H; Jepsen JV; Poulsen AL; Schwartz M; Horn T
    APMIS; 2004 Feb; 112(2):148-52. PubMed ID: 15056232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment.
    Bartoletti R; Dal Canto M; Cai T; Piazzini M; Travaglini F; Gavazzi A; Rizzo M
    Oncol Rep; 2005 Mar; 13(3):531-7. PubMed ID: 15706429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of head and neck tumors by analysis of telomerase activity and a panel of microsatellite markers.
    Fiedler W; Hoppe C; Schimmel B; Koscielny S; Dahse R; Bereczki Z; Claussen U; Ernst G; von Eggeling F
    Int J Mol Med; 2002 Apr; 9(4):417-23. PubMed ID: 11891539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of microsatellite instability in urine in the detection of transitional-cell carcinoma of the bladder.
    Mourah S; Cussenot O; Vimont V; Desgrandchamps F; Teillac P; Cochant-Priollet B; Le Duc A; Fiet J; Soliman H
    Int J Cancer; 1998 Dec; 79(6):629-33. PubMed ID: 9842973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer.
    Kinoshita H; Ogawa O; Kakehi Y; Mishina M; Mitsumori K; Itoh N; Yamada H; Terachi T; Yoshida O
    J Natl Cancer Inst; 1997 May; 89(10):724-30. PubMed ID: 9168188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular urinary sediment analysis in patients with transitional cell bladder carcinoma.
    Dal Canto M; Bartoletti R; Travaglini F; Piazzini M; Lodovichi G; Rizzo M; Selli C
    Anticancer Res; 2003; 23(6D):5095-100. PubMed ID: 14981972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-invasive molecular detection of bladder cancer recurrence.
    Amira N; Mourah S; Rozet F; Teillac P; Fiet J; Aubin P; Cortesse A; Desgrandchamps F; Le Duc A; Cussenot O; Soliman H
    Int J Cancer; 2002 Sep; 101(3):293-7. PubMed ID: 12209982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.